Using Rapid Clozapine Blood Levels to Improve Patient Management
Recorded at the April 2023 Annual Meeting of the American Association of Psychiatric Pharmacists
Description:
Clozapine is the only evidence-based antipsychotic option for treatment-resistant schizophrenia and patients with schizophrenia and suicidality. However, using it demands regular monitoring of a patient’s clozapine blood level. The faculty will discuss how a rapid clozapine blood level can improve managing patients’ care and how to interpret values against the patient’s response and tolerability. Professor Taylor will share his 30 years of experience working with clozapine, implementing a rapid clozapine blood test and blood level guidance that he provides within the South London and Maudsley Trust.
Presenting Faculty:
Additional Resources:
For additional handouts, questions, or inquiries, please contact hello@saladax.com or enter your email below!
